It's a good category, but Pfizer would have to add scale to have it really move the needle. And then just on the product side, just wonder if you guys have an update on the progress of expanding moving up stream to the end zero population. I know that was a big part of the original value proposition with the Medivation deal and just wanted to check on the progress thus far. Thank you.